Jon C. Ogg - Author for 24/7 Wall St.
Lastest Stories by Jon C. Ogg
The analysts at its underwriting firms are quite positive on Beam Therapeutics, now that its post-IPO quiet period has come to an end.
Published:
Last Updated:
Two fresh competing looks at U.S. manufacturing data for the month of February would be considered a mixed bag, aside from comparing the data to China.
Published:
Monday's top analyst upgrades, downgrades and initiations included ABB, Apple, Baidu, Casper Sleep, General Electric, Groupon, JPMorgan, Micron Technology, PPD, Verizon Communications and Wayfair.
Published:
Last Updated:
One of the biggest concerns in the financial markets at this time is that governments and central banks have few obvious policy tools to help keep their economies going if what was seen in China...
Published:
China released its Purchasing Managers Index (PMI) for February and what was expected to be a very bad report showed an even worse reading.
Published:
Jerome Powell has issued a surprise statement that was not on the calendar to address stock market drops and economic uncertainty.
Published:
One of the biggest concerns in the financial markets at this time is that governments and central banks have few obvious policy tools to help keep their economies going if what was seen in China...
Published:
Friday's top analyst upgrades, downgrades and initiations included Beyond Meat, CBOE, Chesapeake Energy, Dollar General, FLIR Systems, Gilead Sciences, Lyft, Novavax, RBS, Uber and Zoom Video...
Published:
Many of the larger biotechnology and pharmaceutical companies have changed strategies from making acquisitions of speculative biotech outfits. In many cases it is far cheaper to just partner up with...
Published:
When you get into crazy markets, sometimes logic and sensibility have to be thrown out the window. General Electric Co. (NYSE: GE) is far from an economically immune company. The company’s...
Published:
24/7 Wall St. has tracked some of the stocks that are either defensive in general or that are actually benefiting from the coronavirus fears.
Published:
Teladoc Health is a company that may actually be winning because of the coronavirus outbreak, even if it likely hasn't seen much of a boost from the virus on its business yet.
Published:
Long-term Treasury yields are at lows that have never been seen before, and parts of the yield curve are inverted. With a fresh case of the coronavirus in the United States, the markets are feeling...
Published:
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems and Virgin Galactic.
Published:
24/7 Wall St. routinely tracks many issues covering the economy and the personal well-being of the average person. With this in mind, we have looked back at our coverage of doomsday preppers from the...
Published: